Sangamo Therapeutics
SGMO
#10549
Rank
C$43.93 M
Marketcap
C$0.11
Share price
0.00%
Change (1 day)
-80.63%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$34.55 Million. In 2025 the company made an earning of -C$0.16 Billion a decrease over its 2024 earnings that were of -C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.16 Billion-1.55%
2025 -C$0.16 Billion9.71%
2024 -C$0.15 Billion-17.27%
2023 -C$0.18 Billion-40.88%
2022 -C$0.29 Billion9.79%
2021 -C$0.27 Billion41.52%
2020 -C$0.19 Billion23.17%
2019 -C$0.16 Billion36.33%
2018 -C$0.12 Billion36.89%
2017 -C$80.78 Million-22.32%
2016 -C$0.11 Billion54.86%
2015 -C$67.16 Million75.62%
2014 -C$38.25 Million0.13%
2013 -C$38.2 Million
2011 -C$51.35 Million43.66%
2010 -C$35.74 Million28.52%
2009 -C$27.81 Million-23.55%
2008 -C$36.38 Million2.45%
2007 -C$35.51 Million19.5%
2006 -C$29.72 Million50.78%
2005 -C$19.71 Million75%
2004 -C$11.26 Million-33.25%
2003 -C$16.87 Million-62.27%
2002 -C$44.71 Million102.82%
2001 -C$22.05 Million23.21%
2000 -C$17.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.83 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.84 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$0.63 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$0.61 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$3.64 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.75 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$62.58 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA